|
May 22
|
Xenetic Biosciences, Inc. Announces Executive Leadership Transition
|
|
May 12
|
Xenetic Biosciences First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
|
|
May 10
|
Xenetic Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
|
|
May 10
|
Xenetic Biosciences (XBIO) Reports Q1 Loss, Misses Revenue Estimates
|
|
Mar 24
|
Xenetic Biosciences Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
|
|
Mar 22
|
Xenetic Biosciences, Inc. Reports Full Year 2023 Financial Results
|
|
Nov 30
|
Most Shareholders Will Probably Agree With Xenetic Biosciences, Inc.'s (NASDAQ:XBIO) CEO Compensation
|